Pharmabiz1h
Annoyed over Union health ministry decision, BDPMA to approach state govt for support of local pharma companies
Annoyed over Union health ministry decision, BDPMA to approach state govt for support of local pharma companies: Peethaambaran Kunnathoor, Chennai Saturday, February 15, 2025, 08: ...
Pharmabiz1h
Seeking comments from industry on extension of revised Schedule M deadline was a fruitless exercise: Industry
Gireesh Babu, New Delhi Saturday, February 15, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Future of dentistry driven by tech as online dental marketplaces gain ground: Dr Vikas Agarwal
Future of dentistry driven by tech as online dental marketplaces gain ground: Dr Vikas Agarwal: Nandita Vijayasimha, Bengaluru Saturday, February 15, 2025, 08:00 Hrs [IST] Dentist ...
Pharmabiz1h
Budget 2025 unveils major boost for small businesses to strengthen pharma MSME exports
Budget 2025 unveils major boost for small businesses to strengthen pharma MSME exports: Shardul Nautiyal, Mumbai Saturday, February 15, 2025, 08:00 Hrs [IST] The Union Budget 2025 ...
Pharmabiz1h
Healthcare and medical services are primary focus in KWIN City, Karnataka
Healthcare and medical services are primary focus in KWIN City, Karnataka: Nandita Vijayasimha, Bengaluru Saturday, February 15, 2025, 08:00 Hrs [IST] Karnataka’s KWIN (Knowledg ...
Pharmabiz15h
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...
Pharmabiz17h
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma: Shanghai Friday, February 14, 2025, 16:00 Hrs [IST] An ...
Pharmabiz18h
Santhera announces agreement with German GKV-SV on reimbursement for Agamree to treat Duchenne muscular dystrophy
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
Pharmabiz16h
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...
Pharmabiz16h
Tivic Health acquires exclusive global rights to TLR5 agonist Entolimod from Statera Biopharma to treat acute radiation syndrome
Fremont, California Friday, February 14, 2025, 17:00 Hrs [IST] ...
Pharmabiz15h
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission: Vaduz, Liechtenstein Friday, February 14, 2025, 18:00 Hrs [IST] Implantica AG (publ.), a ...
Pharmabiz16h
Rusan Pharma’s chairman Dr Navin Saxena conferred with Russia’s prestigious ‘Order of Friendship’ and ‘Academic Honour’
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its chairman, Dr. Navin Saxena, has been honoured with two of Russia’s most distinguished accolades, ‘The ...